Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate.
暂无分享，去创建一个
V. Palombella | Johan A. Pradeilles | Ann M. Rowley | Tao Liu | M. Tremblay | L. Grenier | J. Proctor | M. Pink | J. Ali | T. Tibbitts | Alfredo C Castro | J. P. DiNitto | Erin E Brophy | Catherine A. Evans | André Lescarbeau | S. Nair | Quentin Glenadel | Erin E. Brophy | Erin O’Hearn | D. Winkler | Stanley I. Goldstein | Patrick J. O’Hearn | C. M. Martín | J. Hoyt | J. Soglia | Culver Cheung | Alfredo C. Castro | E. O’Hearn | C. M. Martin | Patrick J O'Hearn | Andre Lescarbeau